Hipoglos

Product NDC
50145-222
11-digit product format
501450222
Labeler code
50145
Product ID
50145-222_62bb10cd-4e99-4e93-a7f5-9dabf692a2d6
Type
HUMAN OTC DRUG
Nonproprietary name
Zinc Oxide and Lanolin
Dosage form
OINTMENT
Route
TOPICAL
Labeler
Laboratorios Andromaco S.A.
Application
part348
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2010-11-03
Marketing end
0000-00-00
Substance
ZINC OXIDE; LANOLIN
Active strength
15 g/100g; g/100g
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct50145-222IInactivated by FDA2026-10-16
excluded packagepackage50145-22250145-222-01IInactivated by FDA2026-10-16
excluded packagepackage50145-22250145-222-02IInactivated by FDA2026-10-16
excluded packagepackage50145-22250145-222-03IInactivated by FDA2026-10-16
excluded packagepackage50145-22250145-222-04IInactivated by FDA2026-10-16
excluded packagepackage50145-22250145-222-05IInactivated by FDA2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 3 · 132 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50145-222-01d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50145-222-02d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50145-222-05d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50145-222-04d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50145-222-03d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50145-222-01f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50145-222-02f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50145-222-05f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50145-222-04f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50145-222-03f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage50145-222-012ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage50145-222-022ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage50145-222-052ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage50145-222-042ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage50145-222-032ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage50145-222-01a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage50145-222-02a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage50145-222-05a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage50145-222-04a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage50145-222-03a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage50145-222-01cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage50145-222-02cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage50145-222-05cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage50145-222-04cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage50145-222-03cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage50145-222-01cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage50145-222-02cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage50145-222-05cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage50145-222-04cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage50145-222-03cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage50145-222-01302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage50145-222-02302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage50145-222-05302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage50145-222-04302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage50145-222-03302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage50145-222-01ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage50145-222-02ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage50145-222-05ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage50145-222-04ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage50145-222-03ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage50145-222-010efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage50145-222-020efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage50145-222-050efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage50145-222-040efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage50145-222-030efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage50145-222-01ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage50145-222-02ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage50145-222-05ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage50145-222-04ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage50145-222-03ad56d346431e…cc804d4bbf1e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50145-222-01Hipoglos120 g in 1 TUBEOINTMENT12012
50145-222-01Hipoglos1 in 1 CARTONOINTMENT112
50145-222-02Hipoglos100 g in 1 TUBEOINTMENT10012
50145-222-02Hipoglos1 in 1 CARTONOINTMENT112
50145-222-03Hipoglos1 in 1 CARTONOINTMENT112
50145-222-03Hipoglos72 g in 1 TUBEOINTMENT7212
50145-222-04Hipoglos60 g in 1 TUBEOINTMENT6012
50145-222-04Hipoglos1 in 1 CARTONOINTMENT112
50145-222-05Hipoglos5 g in 1 TUBEOINTMENT512
50145-222-05Hipoglos1 in 1 CARTONOINTMENT112

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LANOLINACTIVE INGREDIENT7EV65EAW6HHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
ZINC OXIDEACTIVE INGREDIENTSOI2LOH54ZHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
LANOLINACTIVE MOIETY7EV65EAW6HHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
ZINC OXIDEACTIVE MOIETYSOI2LOH54ZHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
ALCOHOLINACTIVE INGREDIENT3K9958V90MHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
BENZETHONIUM CHLORIDEINACTIVE INGREDIENTPH41D05744HIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
COD LIVER OILINACTIVE INGREDIENTBBL281NWFGHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
ENGLISH LAVENDER OILINACTIVE INGREDIENTZBP1YXW0H8HIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
MINERAL OILINACTIVE INGREDIENTT5L8T28FGPHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
PETROLATUMINACTIVE INGREDIENT4T6H12BN9UHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
SORBITAN MONOSTEARATEINACTIVE INGREDIENTNVZ4I0H58XHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
TALCINACTIVE INGREDIENT7SEV7J4R1UHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
VANILLININACTIVE INGREDIENTCHI530446XHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12
WATERINACTIVE INGREDIENT059QF0KO0RHIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50145-222HIPOGLOS (ZINC OXIDE AND LANOLIN) OINTMENT [LABORATORIOS ANDROMACO S.A.]12Legacy NDC, 10 package rows20131105_8e486fed-2316-4297-99d3-9b1a7904d0a7.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1249131lanolin 15 % / zinc oxide 15 % Topical OintmentPSN8e486fed-2316-4297-99d3-9b1a7904d0a712
1249131lanolin 0.15 MG/MG / zinc oxide 0.15 MG/MG Topical OintmentSCD8e486fed-2316-4297-99d3-9b1a7904d0a712
1249131Lanolin 0.15 MG/MG / ZNO 0.15 MG/MG Topical OintmentSY8e486fed-2316-4297-99d3-9b1a7904d0a712
1249131lanolin 15 % / zinc oxide 15 % Topical OintmentSY8e486fed-2316-4297-99d3-9b1a7904d0a712

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
50145-222-0150145022201120 g in 1 TUBE120 gHistorical
50145-222-0250145022202100 g in 1 TUBE100 gHistorical
50145-222-03501450222031 in 1 CARTONHistorical
50145-222-045014502220460 g in 1 TUBE60 gHistorical
50145-222-05501450222055 g in 1 TUBE5 gHistorical